ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis

Lin, Xinqing; Deng, Jiaxi; Deng, Haiyi; Yang, Yilin; Sun, Ni; Zhou, Maolin; Qin, Yinyin; Xie, Xiaohong; Li, Shiyue; Zhong, Nanshan; Song, Yong*; Zhou, Chengzhi*广州医学院; 南方医科大学; 1; y
Frontiers in Immunology2022-1-12DOI: 10.3389/fimmu.2021.818492
13被引11阅读
引用收藏
分享

摘要

BackgroundWhile immune checkpoint inhibitors (ICIs) are a beacon of hope for non-small cell lung cancer (NSCLC) patients, they can also cause adverse events, including checkpoint inhibitor pneumonitis (CIP). Research shows that the inflammatory immune microenvironment plays a vital role in the development of CIP. However, the role of the immune microenvironment (IME) in CIP is still unclear. MethodsWe collected a cohort of NSCLC patients treated with ICIs that included eight individuals with CIP (CIP group) and 29 individuals without CIP (Control group). CIBERSORT and the xCell algorithm were used to evaluate the proportion of immune cells. Gene set enrichment analysis (GSEA) and single-sample GSEA (ssGSEA) were used to evaluate pathway activity. The ridge regression algorithm was used to analyze drug sensitivity. ResultsCIBERSORT showed significantly upregulated memory B cells, CD8+ T cells, and M1 Macrophages in the CIP group. The number of memory resting CD4+ T cells and resting NK cells in the CIP group was also significantly lower than in the Control group. The XCell analysis showed a higher proportion of Class-switched memory B-cells and M1 Macrophages in the CIP group. Pathway analysis showed that the CIP group had high activity in their immune and inflammatory response pathways and low activity in their immune exhaustion related pathway. ConclusionsIn this study, we researched CIP patients who after ICIs treatment developed an inflammatory IME, which is characterized by significantly increased activated immune cells and expression of inflammatory molecules, as well as downregulated immunosuppressive lymphocytes and signaling pathways. The goal was to develop theoretical guidance for clinical guidelines for the treatment of CIP in the future.

学科与关键词

关键词
checkpoint inhibitor pneumonitisimmune infiltrationimmune microenvironmentaberrant pathway activationimmune check inhibitor (ICI)
相关
加载中…
  • Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience
    Lin, Xinqing; Deng, Haiyi; Chen, Likun; Wu, Di; Chen, Xiaobo; Yang, Yilin; Chen, Tao; Xie, Xiaohong; Xie, Zhanhong; Liu, Ming; Ouyang, Ming; Qin, Yinyin; Li, Shiyue; Zhong, Nanshan; Gregg, Jeffrey P.; Horita, Nobuyuki; Song, Yong*; Zhou, Chengzhi*Translational Lung Cancer Research, 2021, 10(1): 415-429.被引 12
  • Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis
    Zhou, Chengzhi; Yang, Yilin; Lin, Xinqing; Fang, Nianxin; Chen, Likun; Jiang, Juhong; Deng, Haiyi; Deng, Yu; Wan, Minghui; Qiu, Guihuan; Sun, Ni; Wu, Di; Long, Xiang; Zhong, Changhao; Xie, Xiaohong; Xie, Zhanhong; Liu, Ming; Ouyang, Ming; Qin, Yinyin; Petrella, Francesco; Fiorelli, Alfonso; Bravaccini, Sara; Kataoka, Yuki; Watanabe, Satoshi; Goto, Taichiro; Solli, Piergiorgio; Igai, Hitoshi; Saito, Yuichi; Tsoukalas, Nikolaos; Nakada, Takeo; Li, Shiyue*; Chen, Rongchang*Frontiers in Immunology, 2022, 13: 935779.被引 6
  • The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Sun, Yueqin; Yang, Qi; Shen, Jie; Wei, Ting; Shen, Weitao; Zhang, Nan; Luo, Peng*; Zhang, Jian*Frontiers in Cell and Developmental Biology, 2021, 09: 745859.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-01-12
卷期
第 12 卷
页码
818492
DOI
10.3389/fimmu.2021.818492
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
State Key Laboratory of Respiratory Disease-The Independent project [SKLRD-Z-202206]; Fundamental and Applied Fundamental Research Project of City-School (Institute); Guangzhou Science and Technology Bureau [202102010357]; Wu Jieping Medical Foundation [320.6750.2020-19-8]; State Key Laboratory of Respiratory Disease-The open project [SKLRD-OP-202111]

作者

  • L

    Lin, Xinqing (第一作者)

    1 · guangzhou med univ · southern med univ

  • D

    Deng, Jiaxi

    1 · guangzhou med univ

查看全部 12 位作者收起作者
  • D

    Deng, Haiyi

    1 · guangzhou med univ

  • Y

    Yang, Yilin

    1 · guangzhou med univ

  • S

    Sun, Ni

    1 · guangzhou med univ

  • Z

    Zhou, Maolin

    1 · guangzhou med univ

  • Q

    Qin, Yinyin

    1 · guangzhou med univ

  • X

    Xie, Xiaohong

    1 · guangzhou med univ

  • L

    Li, Shiyue

    1 · guangzhou med univ

  • Z

    Zhong, Nanshan

    1 · guangzhou med univ

  • S

    Song, Yong (通讯)

    1 · southern med univ

  • Z

    Zhou, Chengzhi (通讯)

    1 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417